Advertisement
Screener

OKYO Pharma Limited (OKYO) Amended Reports

OKYO Pharma Limited Amended Reports

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-08-07: Form 20-F/A; Period of report 2026-03-31; Description 20-F/A; Document form20-fa.htm.
  • 2025-08-12: Form 20-F/A; Period of report 2025-03-31; Description 20-F/A; Document form20-fa.htm.
  • 2023-08-25: Form 20-F/A; Period of report 2023-03-31; Description Annual report of foreign private issuer; Document form20fa.htm.
FiledFormPeriod of reportDescriptionDocument
2026-08-0720-F/A2026-03-3120-F/Aform20-fa.htm
2025-08-1220-F/A2025-03-3120-F/Aform20-fa.htm
2023-08-2520-F/A2023-03-31Annual report of foreign private issuerform20fa.htm